eBriefing

Editor's Guide to Writing and Publishing Your Paper

Editor's Guide to Writing and Publishing Your Paper

Presented By

The New York Academy of Sciences

Overview

Publishing is critical to the scientific profession yet few opportunities exist for science PhDs to gain formal training in this area. At the Disease Drivers of Aging: 2016 Advances in Geroscience Summit, presented by the Gerontological Society of America, the American Federation for Aging Research, the Trans-NIH GeroScience Interest Group, and the New York Academy of Sciences on April 13–14, 2016, Brooke Grindlinger shared her expertise as a former editor for the Journal of Clinical Investigation. Her talk, titled "Editor's Guide to Writing and Publishing Your Paper," gave attendees an inside look into the editorial review process and how to present the results of their work.

Grindlinger covered all the steps from selecting the right journal to dealing with the revision and resubmission process. She delved into manuscript writing, providing tips for how to prepare each section of a paper, and covered the most common mistakes to avoid. She also described the peer review process, including how referees are selected, the common reasons for rejection, and strategies for following up or appealing a negative decision.

Graduate students, postdocs, and junior faculty can all benefit from viewing this seminar. Download the slide presentation in PDF form.

Use the tabs above to find multimedia and additional information from this event.

Presentation available from:
Brooke Grindlinger, PhD (The New York Academy of Sciences)

Editor's Guide to Writing and Publishing Your Paper


Brooke Grindlinger (The New York Academy of Sciences)

Speaker

Brooke Grindlinger, PhD

Chief Scientific Officer, Scientific Programs & Blavatnik Awards
The New York Academy of Sciences

Brooke Grindlinger completed her PhD in microbiology at the School of Molecular and Microbial Biosciences at the University of Sydney, Australia, where she was the recipient of an Australian Postgraduate Award. She used comparative proteomics to study the pathogenesis of the tuberculosis-causing organism Mycobacterium tuberculosis. After relocating to New York, Grindlinger joined the Editorial Board of the Journal of Clinical Investigation. Serving for 7 years as science editor, she managed the publication of state-of-the-art journal content, including Reviews and Commentaries, in all facets of human physiology and disease, and authored news features, editorials, book reviews, and press releases.

Grindlinger joined the Academy in 2010. In her role as Chief Scientific Officer for Scientific Programs & Blavatnik Awards, she leads strategic development and scientific oversight of the Academy's international portfolio of conferences, symposia, workshops, and related multimedia publications across the broad spectrum of Life Sciences, Physical Sciences, Sustainability, Computer Science, and Engineering. In March 2016, Grindlinger was appointed to lead the Blavatnik Awards for Young Scientists, which honor exceptional young scientists and engineers by celebrating their extraordinary achievements, recognizing their inspiring promise, and accelerating their innovations through unrestricted funding.

Sponsors

Silver Sponsor

Academy Friends

Alliance for Aging Research

American Federation for Aging Research

American Geriatrics Society

The Gerontological Society of America

Novartis

Grant Support

Funding for the eBriefing of this conference presentation was made possible, in part, by grant 1 R13 AG 053043-01 from the National Institute on Aging. Co-funding has been provided by the National Institute of Diabetes and Digestive and Kidney Diseases and by the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Gilead Sciences Inc.

Regeneron Pharmaceuticals Inc.



Presented by

  • The Gerontological Society of America